Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by scarlet1967on Oct 21, 2023 8:55pm
251 Views
Post# 35695011

HIV lipodystrophy

HIV lipodystrophy

As she mentioned removing dorsocervical fat( fat on the back of the neck which Tesamorelin effectively also treats ) might need more than one surgical removal, also you can't remove visceral fat which is

behind many metabolic conditions including insulin resistance which per se cause many serious diseases. 

It's absolutely unethical trying to persuade PLWH into costly surgical procedures which doesn't solve any medical issues. In this clip she very quickly mentioned medication but never elaborated, 

It's a disgrace to the profession taking advantage of a patient group of whom many suffering from various physical and psychological conditions, battling the mental challenges due to their disease, the adverse effects of its treatment and the prejudicial effects of being HIV positive homosexual or not. 

https://youtu.be/mlBEuVioxes?feature=shared

<< Previous
Bullboard Posts
Next >>